GENTIAN DIAGNOSTICS ASA (GENT.OL) Stock Fundamental Analysis
Europe • Euronext Oslo • OSL:GENT • NO0010748866
57.8 NOK
+1.8 (+3.21%)
Last: Feb 6, 2026, 07:00 PM
We assign a fundamental rating of 6 out of 10 to GENT. GENT was compared to 63 industry peers in the Health Care Equipment & Supplies industry. While GENT has a great health rating, its profitability is only average at the moment. GENT is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
- GENT had positive earnings in the past year.
- In the past year GENT had a positive cash flow from operations.
- GENT had negative earnings in 4 of the past 5 years.
- In multiple years GENT reported negative operating cash flow during the last 5 years.
1.2 Ratios
- GENT has a better Return On Assets (18.38%) than 97.06% of its industry peers.
- With an excellent Return On Equity value of 21.18%, GENT belongs to the best of the industry, outperforming 89.71% of the companies in the same industry.
- GENT has a better Return On Invested Capital (8.76%) than 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.38% | ||
| ROE | 21.18% | ||
| ROIC | 8.76% |
ROA(3y)0.42%
ROA(5y)-3.57%
ROE(3y)0.25%
ROE(5y)-4.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- GENT has a Profit Margin of 24.80%. This is amongst the best in the industry. GENT outperforms 97.06% of its industry peers.
- With a decent Operating Margin value of 13.44%, GENT is doing good in the industry, outperforming 60.29% of the companies in the same industry.
- GENT's Gross Margin of 55.06% is in line compared to the rest of the industry. GENT outperforms 48.53% of its industry peers.
- In the last couple of years the Gross Margin of GENT has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.44% | ||
| PM (TTM) | 24.8% | ||
| GM | 55.06% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y-7.11%
2. Health
2.1 Basic Checks
- GENT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- GENT has about the same amout of shares outstanding than it did 1 year ago.
- The number of shares outstanding for GENT remains at a similar level compared to 5 years ago.
- GENT has a better debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 18.54 indicates that GENT is not in any danger for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 18.54, GENT belongs to the top of the industry, outperforming 98.53% of the companies in the same industry.
- GENT has a debt to FCF ratio of 0.59. This is a very positive value and a sign of high solvency as it would only need 0.59 years to pay back of all of its debts.
- With an excellent Debt to FCF ratio value of 0.59, GENT belongs to the best of the industry, outperforming 95.59% of the companies in the same industry.
- A Debt/Equity ratio of 0.01 indicates that GENT is not too dependend on debt financing.
- GENT has a better Debt to Equity ratio (0.01) than 92.65% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.59 | ||
| Altman-Z | 18.54 |
ROIC/WACC1.03
WACC8.51%
2.3 Liquidity
- GENT has a Current Ratio of 5.98. This indicates that GENT is financially healthy and has no problem in meeting its short term obligations.
- GENT's Current ratio of 5.98 is amongst the best of the industry. GENT outperforms 98.53% of its industry peers.
- GENT has a Quick Ratio of 4.16. This indicates that GENT is financially healthy and has no problem in meeting its short term obligations.
- GENT's Quick ratio of 4.16 is amongst the best of the industry. GENT outperforms 95.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.98 | ||
| Quick Ratio | 4.16 |
3. Growth
3.1 Past
- GENT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 2066.40%, which is quite impressive.
- The Revenue has grown by 17.42% in the past year. This is quite good.
- GENT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 25.96% yearly.
EPS 1Y (TTM)2066.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.54%
Revenue 1Y (TTM)17.42%
Revenue growth 3Y22.3%
Revenue growth 5Y25.96%
Sales Q2Q%27.94%
3.2 Future
- Based on estimates for the next years, GENT will show a very strong growth in Earnings Per Share. The EPS will grow by 62.29% on average per year.
- Based on estimates for the next years, GENT will show a very strong growth in Revenue. The Revenue will grow by 31.72% on average per year.
EPS Next Y59.41%
EPS Next 2Y62.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year31.13%
Revenue Next 2Y31.72%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 21.17, GENT is valued on the expensive side.
- 76.47% of the companies in the same industry are more expensive than GENT, based on the Price/Earnings ratio.
- GENT's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.93.
- A Price/Forward Earnings ratio of 21.30 indicates a rather expensive valuation of GENT.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of GENT is on the same level as its industry peers.
- Compared to an average S&P500 Price/Forward Earnings ratio of 27.77, GENT is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.17 | ||
| Fwd PE | 21.3 |
4.2 Price Multiples
- GENT's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. GENT is more expensive than 66.18% of the companies in the same industry.
- GENT's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. GENT is more expensive than 64.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 274.32 | ||
| EV/EBITDA | 25.03 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A more expensive valuation may be justified as GENT's earnings are expected to grow with 62.29% in the coming years.
PEG (NY)0.36
PEG (5Y)N/A
EPS Next 2Y62.29%
EPS Next 3YN/A
5. Dividend
5.1 Amount
- GENT has a yearly dividend return of 0.70%, which is pretty low.
- GENT's Dividend Yield is comparable with the industry average which is at 0.97.
- Compared to an average S&P500 Dividend Yield of 1.81, GENT's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.7% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y62.29%
EPS Next 3YN/A
OSL:GENT (2/6/2026, 7:00:00 PM)
57.8
+1.8 (+3.21%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners39.37%
Inst Owner ChangeN/A
Ins Owners2.6%
Ins Owner ChangeN/A
Market Cap891.28M
Revenue(TTM)172.52M
Net Income(TTM)42.78M
Analysts85.71
Price Target68.34 (18.24%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.7% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.17 | ||
| Fwd PE | 21.3 | ||
| P/S | 5.17 | ||
| P/FCF | 274.32 | ||
| P/OCF | 71.88 | ||
| P/B | 4.41 | ||
| P/tB | 5.25 | ||
| EV/EBITDA | 25.03 |
EPS(TTM)2.73
EY4.72%
EPS(NY)2.71
Fwd EY4.69%
FCF(TTM)0.21
FCFY0.36%
OCF(TTM)0.8
OCFY1.39%
SpS11.19
BVpS13.1
TBVpS11.01
PEG (NY)0.36
PEG (5Y)N/A
Graham Number28.37
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.38% | ||
| ROE | 21.18% | ||
| ROCE | 11.37% | ||
| ROIC | 8.76% | ||
| ROICexc | 15.22% | ||
| ROICexgc | 21.01% | ||
| OM | 13.44% | ||
| PM (TTM) | 24.8% | ||
| GM | 55.06% | ||
| FCFM | 1.88% |
ROA(3y)0.42%
ROA(5y)-3.57%
ROE(3y)0.25%
ROE(5y)-4.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y-7.11%
F-Score5
Asset Turnover0.74
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.59 | ||
| Debt/EBITDA | 0.06 | ||
| Cap/Depr | 101.32% | ||
| Cap/Sales | 5.3% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 38.48% | ||
| Profit Quality | 7.6% | ||
| Current Ratio | 5.98 | ||
| Quick Ratio | 4.16 | ||
| Altman-Z | 18.54 |
F-Score5
WACC8.51%
ROIC/WACC1.03
Cap/Depr(3y)104.09%
Cap/Depr(5y)116.83%
Cap/Sales(3y)8.32%
Cap/Sales(5y)10.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2066.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.54%
EPS Next Y59.41%
EPS Next 2Y62.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)17.42%
Revenue growth 3Y22.3%
Revenue growth 5Y25.96%
Sales Q2Q%27.94%
Revenue Next Year31.13%
Revenue Next 2Y31.72%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y260.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year215.39%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y127.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y285.08%
OCF growth 3YN/A
OCF growth 5YN/A
GENTIAN DIAGNOSTICS ASA / GENT.OL FAQ
Can you provide the ChartMill fundamental rating for GENTIAN DIAGNOSTICS ASA?
ChartMill assigns a fundamental rating of 6 / 10 to GENT.OL.
Can you provide the valuation status for GENTIAN DIAGNOSTICS ASA?
ChartMill assigns a valuation rating of 4 / 10 to GENTIAN DIAGNOSTICS ASA (GENT.OL). This can be considered as Fairly Valued.
Can you provide the profitability details for GENTIAN DIAGNOSTICS ASA?
GENTIAN DIAGNOSTICS ASA (GENT.OL) has a profitability rating of 4 / 10.
How financially healthy is GENTIAN DIAGNOSTICS ASA?
The financial health rating of GENTIAN DIAGNOSTICS ASA (GENT.OL) is 9 / 10.
What is the earnings growth outlook for GENTIAN DIAGNOSTICS ASA?
The Earnings per Share (EPS) of GENTIAN DIAGNOSTICS ASA (GENT.OL) is expected to grow by 59.41% in the next year.